Colinz Laboratories

Colinz Laboratories, established in 1986, specializes in the manufacturing and export of pharmaceutical formulations, including allopathic, ayurvedic, and nutraceutical products. Their operations are supported by a WHO-certified site, ensuring adherence to international quality standards for their diverse product range. This commitment makes them a key player for businesses in the pharmaceutical and healthcare sectors seeking reliable medicinal solutions. The company focuses on delivering high-quality pharmaceutical products to a global market.

The company's product forms include tablets, capsules, ointments, injectables, syrups, and suppositories. With an employee base of 1,000 to 5,000 individuals and operations across 2 locations, Colinz Laboratories possesses substantial operational capacity. For insights into their leadership and personnel, interested parties can explore Meet Colinz Laboratories' team. The company generated a revenue of $0.8M, indicating its market standing and operational output.

Colinz Laboratories' primary clientele comprises businesses within the pharmaceutical and healthcare industries. Headquartered in Mumbai, Maharashtra, India, the company is strategically positioned within a major pharmaceutical hub in Asia. Listed on the Bombay Stock Exchange under the ticker BSE: 531210, Colinz Laboratories maintains transparency and accessibility for stakeholders. Its operations are rooted in the Indian market, contributing to the pharmaceutical landscape.